Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged?

Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged?

Bibliographic Details
Main Author:	Jay B. Wish
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	Kidney Medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590059520301801

Similar Items

Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling EraPlain-Language Summary
by: Borut Cizman, et al.
Published: (2020-09-01)

Factors associated with erythropoiesis-stimulating agent hyporesponsiveness anemia in chronic kidney disease patients.
by: Kamalas Amnuay, et al.
Published: (2019-09-01)

In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: a population-based study
by: Ylenia Ingrasciotta, et al.
Published: (2019-09-01)

Correction to: In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: a population-based study
by: Ylenia Ingrasciotta, et al.
Published: (2020-07-01)

Association between Dipeptidyl Peptidase-4 Inhibitor Prescription and Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients with Diabetes Mellitus
by: Takeshi Hasegawa, et al.
Published: (2021-04-01)

Hyporesponsiveness to long-acting erythropoiesis-stimulating agent is related to the risk of cardiovascular disease and death in Japanese patients on chronic hemodialysis: observational cohort study
by: Kenichi Tanaka, et al.
Published: (2021-03-01)

Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective
by: Matti Aapro, et al.
Published: (2019-01-01)

Erythropoiesis stimulating agents approaches to modulate activity
by: Sinclair AM
Published: (2013-07-01)

Helicobacter pylori and Duodenal Ulcer: Guilty as Charged
by: SD Shafran, et al.
Published: (1994-01-01)

Guilty as charged? : the effect of interpreting on interviews with suspects
by: Russell, Sonia C.
Published: (2001)

Guilty Until Proven Guilty
by: Shivangi Narayan
Published: (2021-09-01)

Lessons from clinical trials with erythropoiesis-stimulating agents (ESAs)
by: Tilman B. Drüeke
Published: (2018-11-01)

Treatment of renal anemia: Erythropoiesis stimulating agents and beyond
by: Patrick Biggar, et al.
Published: (2017-09-01)

Use of erythropoiesis-stimulating agents in obese hemodialysis patients
by: Sun-Hee Park
Published: (2018-09-01)

Timing-adjusted iron dosing enhances erythropoiesis-stimulating agent-induced erythropoiesis response and iron utilization
by: Tomoyuki Kawano, et al.
Published: (2017-05-01)

Hyporesponsiveness Induced by Anaphylaxis
by: Miao-Chen Chou, et al.
Published: (1994)

Not guilty
by: Michel Deguy, et al.
Published: (2011-12-01)

Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents
by: N. A. Romanenko, et al.
Published: (2014-07-01)

Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents
by: N. A. Romanenko, et al.
Published: (2014-07-01)

ESA Hyporesponsiveness Is Associated with Adverse Events in Maintenance Hemodialysis (MHD) Patients, But Not with Iron Storage.
by: Takahiro Kuragano, et al.
Published: (2016-01-01)

Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
by: Hirokazu Honda, et al.
Published: (2016-01-01)

Guilty, or not guilty?: a short story of propofol abuse
by: Sangseok Lee
Published: (2013-11-01)

Erythropoiesis Stimulation in Patients with Postoperative Anemia
by: D. B. Borisov, et al.
Published: (2013-08-01)

Anaemia and heart failure: is there still a role for erythropoiesis-stimulating agents?
by: Massimo Volpe, et al.
Published: (2017-04-01)

The Effect of Erythropoiesis-Stimulating Agents on Platelet Aggregation in Peritoneal Dialysis Patients
by: Serkan Bakırdöğen, et al.
Published: (2019-11-01)

Are erythropoiesis-stimulating agents beneficial for anemia in chronic heart failure patients?
by: Diego Araneda, et al.
Published: (2016-12-01)

Effect of erythropoiesis-stimulating agents on blood pressure in pre-dialysis patients.
by: Marit M Suttorp, et al.
Published: (2013-01-01)

Guilty of not doing that!
by: Marco Mazzocca
Published: (2020-12-01)

Guilty of not doing that!
by: Marco Mazzocca
Published: (2020-12-01)

Temporal Trends in Hemoglobin, Use of Erythropoiesis Stimulating Agents, and Major Clinical Outcomes in Incident Dialysis Patients in Canada
by: Mark Canney, et al.
Published: (2021-04-01)

Resistance to Erythropoiesis-Stimulating Agents Is Associated with Arterial Microcalcification in Early Hemodialysis Patients
by: Hye Sung Won, et al.
Published: (2014-01-01)

Association of malnutrition-inflammation complex and responsiveness to erythropoiesis stimulating agents in hemodialysis patients
by: Manoch Rattanasompattikul, et al.
Published: (2012-06-01)

Dosing of Erythropoiesis-Stimulating Agents Can Be Reduced by a New Administration Regimen
by: Bergur V. Stefánsson, et al.
Published: (2011-08-01)

Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma
by: Horváth-Puhó E, et al.
Published: (2018-09-01)

Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review)
by: N. A. Romanenko, et al.
Published: (2014-07-01)

Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review)
by: N. A. Romanenko, et al.
Published: (2014-07-01)

Preoperative Stimulation of Erythropoiesis in Patients with Anemia
by: V. I. Zagrekov, et al.
Published: (2010-04-01)

Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after the TREAT trial
by: Khoa Vu, et al.
Published: (2021-08-01)

The influence of vitamin E bonded haemodialysis membranes on erythropoiesis stimulating agent requirements, oxidative stress, inflammation, haemostasis and outcomes
by: Lines, Simon
Published: (2013)

When is asthma not guilty?
by: Abdullah Al Shamrani, FRCPCH, et al.
Published: (2021-12-01)

Cannot write session to /tmp/vufind_sessions/sess_1bjgrs5ftra9fepin14385qlno